semaglutide 40 mg ODT Tablet (1 mg) Semaglutide 40 Units: Dosing Guide

1 Weight loss results: Tirzepatide: approximately 12% body weight loss from baseline Dulaglutide 1.5 mg: approximately 5% body weight loss from baseline Difference: roughly 7 percentage points in favour of tirzepatide Blood sugar control: Tirzepatide: -1.73% HbA1c reduction Dulaglutide 1.5 mg: -0.90% HbA1c reduction Difference: approximately 0.83 percentage points in favour of tirzepatide Cardiovascular outcomes Both medications have demonstrated cardiovascular safety and benefit in people with type 2 diabetes

GLP-1s tied to lower risk for 10 types of cancer compared with insulin in type 2 diabetes People with type 2 diabetes who use a GLP-1 receptor agonist have a lower risk for 10 types of obesity-associated cancer compared with those who use insulin, according to data published in JAMA Network Open

PMID: 32558293 | doi:10.1002/brb3.1726 Gwyer D et al

What happens to myelin in MS

And you dont have to take our word for it